InvestorsObserver
Sign Up Login

ASLN Aslan Pharmaceuticals Ltd ADR

$0.60 $0.01 (2.46%)
Add to Watchlist Compare
Overall

ASLN Stock Analysis Overview

What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

ASLN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

ASLN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

ASLN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

ASLN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

ASLN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

ASLN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

ASLN Stock Analysis Overview

What this means: Aslan Pharmaceuticals Ltd ADR (ASLN) gets an Overall Rank of 57, which is an above average rank under InvestorsObserver's stock ranking system. Our system considers the available information about the company and then compares it to all the other stocks we have data on to get a percentile-ranked value. ASLN's 57 means that it ranks higher than 57% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full ASLN report

ASLN Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

ASLN Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

ASLN Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

ASLN Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

ASLN Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

ASLN Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Aslan Pharmaceuticals Ltd ADR (ASLN) Analyst Forecast

ASLN Price, Volume, Earnings, and Dividend Date

  • Last Price $0.60
  • Previous Close $0.59
  • Change $0.01
  • Open $0.61
  • Volume 82,030
  • Avg. Volume (100-day) 230,675
  • Market Cap 41,846,804
  • Days Range 0.6 - 0.615
  • 52-week Range 0.36 - 1.91
  • Dividend Yield —
  • Ex. Dividend Date —
  • P-E —
  • EPS —
  • Earnings Date 10/25/22
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 0.829
  • PEG Ratio —

Aslan Pharmaceuticals Ltd ADR (ASLN) Company Description

ASLAN Pharmaceuticals Ltd is a clinical-stage immunology focused biopharmaceutical company developing innovative treatments to transform the lives of patients. The company is evaluating ASLAN004, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and ASLAN003, a potent oral inhibitor of DHODH, which is being developed for autoimmune disease.

Aslan Pharmaceuticals Ltd ADR (ASLN) Stock Chart

View Interactive ASLN chart

My Watchlists

Follow Your Favorite Stocks

Top Stocks in Biotechnology

Company Price
Ardelyx Inc (ARDX) (ARDX) $1.36
Liquidia Corp (LQDA) (LQDA) $5.63
Minerva Neuroscie (NERV) (NERV) $9.64
Axsome Thera (AXSM) (AXSM) $46.61
Satsuma Pharmaceuticals Inc (STSA) (STSA) $5.71
Pliant Therapeutics Inc (PLRX) (PLRX) $21.65
G1 Therapeutics Inc (GTHX) (GTHX) $12.36
Fireman B.V. (IFRX) (IFRX) $2.65
Logicbio Therapeutics Inc (LOGC) (LOGC) $2.02
Wave Life Sci Ord Sh (WVE) (WVE) $3.62